510(k) Report

510(k) · Cleared

Cleared

Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles

K202267510(k) TraditionalCleared Dec 31, 2020142-day reviewClass II21 CFR 892.5730

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Isoray Medical, Inc. · KXK Source, Brachytherapy, Radionuclide

Cleared on Dec 31, 2020 as substantially equivalent to K092458 (Isoray Medical, Inc., 2009) after a 142-day review. Its family tree reaches back 7 generations to 1980.

Decided
Dec 31, 2020
Review
142 days
Class
Class II
Product code
KXK
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K801748 (1980). 25 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 7 generations backK801748 3M I-125 Seeds in Absorbable Carrier3M Company · 1980
  2. 6 generations backK982226 Uromed Brachytheraphy Iodine-125 SourcesUromed Corp. · 1999
  3. 5 generations backK021343 Isoseeds I-125Bebig Isotopen-Und Medizintechnik GmbH · 2002
  4. 4 generations backK040339 Brachytherapy Strand DeviceBebig Isotopen-Und Medizintechnik GmbH · 2004
  5. 3 generations backK043596 Theraload Custom Loaded Needles, Models 200 and 125.S06Theragenics Corp. · 2005
  6. 2 generations backK062384 Cesium-131 Strand, Strand Preload, Preload, S-CartridgeIsoray, Inc. · 2006
  7. 1 generation backK092458 Proxcelan CS-131PRELOADED Strands, Model PL-1, Proxcelan CS-131…Isoray Medical, Inc. · 2009
  8. This deviceK202267 Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers…Isoray Medical, Inc. · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K8017483M I-125 Seeds in Absorbable Carrier3M Company1980—
−6K982226Uromed Brachytheraphy Iodine-125 SourcesUromed Corp.1999—
−5K021343Isoseeds I-125Bebig Isotopen-Und Medizintechnik GmbH2002—
−4K040339Brachytherapy Strand DeviceBebig Isotopen-Und Medizintechnik GmbH2004—
−3K043596Theraload Custom Loaded Needles, Models 200 and 125.S06Theragenics Corp.2005—
−2K062384Cesium-131 Strand, Strand Preload, Preload, S-CartridgeIsoray, Inc.2006—
−1K092458Proxcelan CS-131PRELOADED Strands, Model PL-1, Proxcelan CS-131 Preloaded…Isoray Medical, Inc.2009—
0 (this device)K202267Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18…Isoray Medical, Inc.2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199110
199310
199410
199510
199720
199810
199910
200130
200220
200320
200410
200510
FIG. 1 — Lineage of K202267, 1980–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KXK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KXK device

  1. #1 K242818 IsoSpherescore 10.9 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K092458Proxcelan CS-131PRELOADED Strands, Model PL-1, Proxcelan CS-131 Preloaded Strands in 18…
Summary page 5
…evice: Legally marketed device to which substantial equivalence is claimed: Proxcelan (Cesium-131) Implant Devices, Multiple Configurations (K092458) Reference Device: SiriusTM MRI Marker NS (K171487) Device Description The Isoray Medical, Inc. Cs-131 Implant Devices with…
Isoray Medical, Inc.2009—
†K171487Sirius MRI Marker NSC4 Imaging, LLC2017—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 40 years and passes through 6 companies; a new generation was cleared every 2.8 years on median.
  • 2 of the 25 ancestors have a recall of any class.

How does its category compare?

All KXK devices

KXK Source, Brachytherapy, Radionuclide: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · KXK

2in 2025

2007: 52008: 12009: 72010: 12011: 52012: 32013: 32014: 82015: 22016: 42017: 22018: 12019: 22020: 32022: 12023: 12025: 2
2007high 8 (2014) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KXK

158in 2020

2007: 42 days median2009: 63 days median2011: 94 days median2012: 109 days median2013: 127 days median2014: 96 days median2016: 49 days median2020: 158 days median
2007high 158 (2020) · low 42 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KXK

1in 2016

2008: 12011: 12012: 12016: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KXK

7in 2025

2007: 92008: 152009: 102011: 352012: 42013: 292014: 132015: 62016: 402017: 412018: 282019: 102020: 152021: 622022: 262023: 92024: 152025: 7
2007high 62 (2021) · low 0 (2010)2025

MAUDE reports naming product code KXK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200754209
20081—115
2009763010
20101—00
2011594135
2012310914
20133127029
2014896013
20152—06
2016449140
20172—041
20181—028
20192—010
20203158015
20210—062
20221—026
20231—09
20240—015
20252—07
20260—0—

What is it indicated for?

The Isoray Medical, Inc. Cs-131 Implant Devices with SiriusTM MRI Markers are indicated for the treatment of

malignant prostatic disease. These devices may be used as a primary treatment or in conjunction with other modalities.

The MRI Markers are used to facilitate the anatomical localization of seeds after they have been implanted.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K202267: Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K202267

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026